{
    "2019-08-07": [
        [
            {
                "time": "2019-08-07",
                "original_text": "Johnson Fistel Launches Investigation into Novartis AG; Investors Encouraged to Contact Firm",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Investigation",
                        "Investors"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-08-07",
                "original_text": "2 Marijuana Stocks to Buy Heading into Q2 Earnings and Beyond",
                "features": {
                    "keywords": [
                        "Marijuana",
                        "Stocks",
                        "Q2",
                        "Earnings"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "cannabis"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-08-07",
                "original_text": "Law Offices of Howard G. Smith Announces Investigation on Behalf of Novartis AG Investors (NVS)",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Investigation",
                        "Investors"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-08-07",
                "original_text": "Medicare to cover expensive cancer cell therapies",
                "features": {
                    "keywords": [
                        "Medicare",
                        "Cancer",
                        "Therapies"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-08-07",
                "original_text": "Codexis Rolls Into Second Half Armed with Cash",
                "features": {
                    "keywords": [
                        "Codexis",
                        "Cash",
                        "Second Half"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-08-07",
                "original_text": "Horizon Stock Pops On Beat And Raise As Another Drugmaker Reverses",
                "features": {
                    "keywords": [
                        "Horizon",
                        "Stock",
                        "Beat",
                        "Raise"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-08-07",
                "original_text": "Mallinckrodt (MNK) Q2 Earnings Beat, Generics Spin-off on Hold",
                "features": {
                    "keywords": [
                        "Mallinckrodt",
                        "Q2",
                        "Earnings",
                        "Generics",
                        "Spin-off"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-08-07",
                "original_text": "Conatus (CNAT) Beats on Q2 Earnings, Stops Emricasan Studies",
                "features": {
                    "keywords": [
                        "Conatus",
                        "Q2",
                        "Earnings",
                        "Emricasan",
                        "Studies"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-08-07",
                "original_text": "FDA Investigates Data Manipulation Issue With Newly Approved Novartis Drug Zolgensma",
                "features": {
                    "keywords": [
                        "FDA",
                        "Data",
                        "Manipulation",
                        "Novartis",
                        "Zolgensma"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-08-07",
                "original_text": "Novartis says it knew of Zolgensma data problems before U.S. approval",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Zolgensma",
                        "Data",
                        "Problems",
                        "Approval"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-08-07",
                "original_text": "Akcea Therapeutics, Inc. (AKCA) Q2 2019 Earnings Call Transcript",
                "features": {
                    "keywords": [
                        "Akcea",
                        "Q2",
                        "Earnings",
                        "Call",
                        "Transcript"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-08-07",
                "original_text": "The Daily Biotech Pulse: Novartis Stands By Zolgensma, GW Pharma Q2 Propelled By Epidiolex Sales, Ionis-Akcea Clinical Readout",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Zolgensma",
                        "GW Pharma",
                        "Epidiolex",
                        "Ionis-Akcea",
                        "Clinical",
                        "Readout"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-08-07",
                "original_text": "[video] FDA Says Some Data From Novartis Gene Therapy Manipulated",
                "features": {
                    "keywords": [
                        "FDA",
                        "Data",
                        "Manipulated",
                        "Novartis",
                        "Gene",
                        "Therapy"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}